
Sign up to save your podcasts
Or


In this episode of the Talking Biotech podcast, Dr. Jackie Douglas discusses the emerging field of neoantigens and their significance in cancer immunotherapy. Neoantigens, which are unique to cancer cells, offer a promising target for personalized immunotherapies. The conversation covers the formation of neoantigens, the role of HLA alleles in their presentation, recent advances in research, and various therapeutic strategies being explored. Challenges such as patient response variability and the need for affordable treatments are also highlighted, along with the potential for future developments in the field.
By Colabra4.8
273273 ratings
In this episode of the Talking Biotech podcast, Dr. Jackie Douglas discusses the emerging field of neoantigens and their significance in cancer immunotherapy. Neoantigens, which are unique to cancer cells, offer a promising target for personalized immunotherapies. The conversation covers the formation of neoantigens, the role of HLA alleles in their presentation, recent advances in research, and various therapeutic strategies being explored. Challenges such as patient response variability and the need for affordable treatments are also highlighted, along with the potential for future developments in the field.

32,245 Listeners

6,956 Listeners

30,708 Listeners

43,588 Listeners

9,209 Listeners

4,020 Listeners

2,057 Listeners

604 Listeners

758 Listeners

3,660 Listeners

12,138 Listeners

817 Listeners

6,442 Listeners

113,300 Listeners

4,171 Listeners